TTNP of course we all understand that no biotech is a sure thing but the chances of TTNP getting a CRL is slim to none imo...
Besides Priority Review which increases FDA approval rates to 75% TTNP submitted their NDA under a 505b application as the drug buprenorphine has been approved & in use since 2003, both safe & effective. Besides that has become the gold standard in opioid abuse treatment with a 58% CAGR & sales topping 1.4 Billion $$$$ a year.....couple both together gives TTNP a 90% + approval chance again imo... GLTY & make $$$$$$$$$$
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.